2024 |
Zenas Biopharma Inc.
|
Independent Director |
495.0 K |
- |
2024 |
Vera Therapeutics Inc - Ordinary Shares - Class A
|
Independent Director |
438.6 K |
- |
2024 |
BioAge Labs Inc.
|
Independent Director |
231.1 K |
- |
2024 |
Jazz Pharmaceuticals plc
|
Independent Director |
- |
- |
2023 |
Jazz Pharmaceuticals plc
|
Independent Director |
526.3 K |
9.4 % |
2022 |
Jazz Pharmaceuticals plc
|
Independent Director |
481.2 K |
2.2 % |
2022 |
Vera Therapeutics Inc - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2021 |
Jazz Pharmaceuticals plc
|
Independent Director |
470.6 K |
-32.0 % |
2021 |
Vera Therapeutics Inc - Ordinary Shares - Class A
|
Independent Director |
95.0 K |
- |
2020 |
Jazz Pharmaceuticals plc
|
Independent Director |
691.7 K |
26.3 % |
2020 |
Vaxcyte Inc
|
Independent Director |
- |
- |
2020 |
Vera Therapeutics Inc - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2019 |
Jazz Pharmaceuticals plc
|
Independent Director |
547.6 K |
-2.1 % |
2019 |
Vaxcyte Inc
|
Independent Director |
- |
- |
2018 |
Jazz Pharmaceuticals plc
|
Independent Director |
559.4 K |
31.3 % |
2017 |
Jazz Pharmaceuticals plc
|
Independent Director |
426.2 K |
5.0 % |
2017 |
Corcept Therapeutics Inc
|
Independent Director |
- |
- |
2016 |
Jazz Pharmaceuticals plc
|
Independent Director |
405.7 K |
-21.2 % |
2016 |
Corcept Therapeutics Inc
|
Independent Director |
162.4 K |
-23.2 % |
2016 |
Esperion Therapeutics Inc.
|
Independent Director |
- |
- |
2015 |
Esperion Therapeutics Inc.
|
Independent Director |
563.3 K |
502.5 % |
2015 |
Jazz Pharmaceuticals plc
|
Independent Director |
515.1 K |
12.4 % |
2015 |
Corcept Therapeutics Inc
|
Independent Director |
211.4 K |
135.8 % |
2014 |
Jazz Pharmaceuticals plc
|
Independent Director |
458.2 K |
5.0 % |
2014 |
Esperion Therapeutics Inc.
|
Independent Director |
93.5 K |
-56.5 % |
2014 |
Corcept Therapeutics Inc
|
Independent Director |
89.6 K |
1.2 % |
2013 |
Jazz Pharmaceuticals plc
|
Independent Director |
436.4 K |
49.5 % |
2013 |
Esperion Therapeutics Inc.
|
Independent Director |
214.8 K |
- |
2013 |
Corcept Therapeutics Inc
|
Independent Director |
88.6 K |
-30.6 % |
2012 |
Jazz Pharmaceuticals plc
|
Independent Director |
292.0 K |
213.7 % |
2012 |
Corcept Therapeutics Inc
|
Independent Director |
127.6 K |
-8.7 % |
2012 |
Esperion Therapeutics Inc.
|
Independent Director |
- |
- |
2011 |
Corcept Therapeutics Inc
|
Independent Director |
139.6 K |
34.4 % |
2011 |
Jazz Pharmaceuticals plc
|
Independent Director |
93.1 K |
-5.2 % |
2010 |
Corcept Therapeutics Inc
|
Independent Director |
103.9 K |
122.3 % |
2010 |
Jazz Pharmaceuticals plc
|
Independent Director |
98.2 K |
-41.8 % |
2009 |
Jazz Pharmaceuticals plc
|
Director |
168.7 K |
- |
2009 |
Corcept Therapeutics Inc
|
Director |
46.7 K |
21.2 % |
2008 |
Corcept Therapeutics Inc
|
Director |
38.6 K |
- |
2008 |
Jazz Pharmaceuticals plc
|
Director |
- |
- |
2007 |
Molecular Templates Inc
|
Director |
29.5 K |
-73.0 % |
2007 |
Corcept Therapeutics Inc
|
Director |
- |
- |
2006 |
Molecular Templates Inc
|
Director |
109.3 K |
- |
2005 |
Molecular Templates Inc
|
Director |
- |
- |
2004 |
Molecular Templates Inc
|
Director |
- |
- |